3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
2
Prostatic Neoplasms
1
Multiple Myeloma
1
Lung Neoplasms
1
Leukemia, Plasma Cell
1
Ganglioneuroblastoma
1
Adenoma, Islet Cell
1
Interventions
Whole-Body Irradiation
5
fludarabine phosphate
4
Cyclophosphamide
4
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cyclosporine
3
Busulfan
3
Tacrolimus
2
Methotrexate
2
Melphalan
2
Etoposide
2
Azacitidine
2
venetoclax
1
merphos
1
ivosidenib
1
fludarabine
1
Vorinostat
1
Thiotepa
1
TAK-243
1
Specimen Handling
1
Sirolimus
1
Rituximab
1
Lenalidomide
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
Biopsy
1
Antilymphocyte Serum
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Refractory, with Excess of Blasts
×
sargramostim
×
30 days
×
Clear all
No trials found.